165 related articles for article (PubMed ID: 38452266)
21. MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people.
Glintborg D; T'Sjoen G; Ravn P; Andersen MS
Eur J Endocrinol; 2021 Jun; 185(2):R49-R63. PubMed ID: 34081614
[TBL] [Abstract][Full Text] [Related]
22. Adherence to Gender Affirming Hormone Therapy in Transgender Adolescents and Adults: A Retrospective Cohort Study.
Gupta P; Patterson BC; Chu L; Gold S; Amos S; Yeung H; Goodman M; Tangpricha V
J Clin Endocrinol Metab; 2023 Oct; 108(11):e1236-e1244. PubMed ID: 37246711
[TBL] [Abstract][Full Text] [Related]
23. Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks.
Sudhakar D; Huang Z; Zietkowski M; Powell N; Fisher AR
Neurourol Urodyn; 2023 Jun; 42(5):903-920. PubMed ID: 36403287
[TBL] [Abstract][Full Text] [Related]
24. Thrombosis Risk in Transgender Adolescents Receiving Gender-Affirming Hormone Therapy.
Mullins ES; Geer R; Metcalf M; Piccola J; Lane A; Conard LAE; Mullins TLK
Pediatrics; 2021 Apr; 147(4):. PubMed ID: 33753543
[TBL] [Abstract][Full Text] [Related]
25. Fertility preservation for transgender adolescents and young adults: a systematic review.
Baram S; Myers SA; Yee S; Librach CL
Hum Reprod Update; 2019 Nov; 25(6):694-716. PubMed ID: 31633751
[TBL] [Abstract][Full Text] [Related]
26. Breakthrough Bleeding in Transgender and Gender Diverse Adolescents and Young Adults on Long-Term Testosterone.
Grimstad F; Kremen J; Shim J; Charlton BM; Boskey ER
J Pediatr Adolesc Gynecol; 2021 Oct; 34(5):706-716. PubMed ID: 33910088
[TBL] [Abstract][Full Text] [Related]
27. Headache in transgender and gender-diverse patients: A narrative review.
Hranilovich JA; Kaiser EA; Pace A; Barber M; Ziplow J
Headache; 2021 Jul; 61(7):1040-1050. PubMed ID: 34363408
[TBL] [Abstract][Full Text] [Related]
28. Sublingual Estradiol Is Associated with Higher Estrone Concentrations than Transdermal or Injectable Preparations in Transgender Women and Gender Nonbinary Adults.
Cirrincione LR; Winston McPherson G; Rongitsch J; Sadilkova K; Drees JC; Krasowski MD; Dickerson JA; Greene DN
LGBT Health; 2021; 8(2):125-132. PubMed ID: 33439749
[No Abstract] [Full Text] [Related]
29. Addition of progesterone to feminizing gender-affirming hormone therapy in transgender individuals for breast development: a randomized controlled trial.
Dijkman BAM; Helder D; Boogers LS; Gieles NC; van Heesewijk JO; Slaa ST; Liberton NPTJ; Wiepjes CM; de Blok CJM; den Heijer M; Dreijerink KMA
BMC Pharmacol Toxicol; 2023 Dec; 24(1):80. PubMed ID: 38124194
[TBL] [Abstract][Full Text] [Related]
30. Does Gender-Affirming Hormonal Treatment Affect 30-Year Cardiovascular Risk in Transgender Persons? A Two-Year Prospective European Study (ENIGI).
Cocchetti C; Castellini G; Iacuaniello D; Romani A; Maggi M; Vignozzi L; Schreiner T; den Heijer M; T'Sjoen G; Fisher AD
J Sex Med; 2021 Apr; 18(4):821-829. PubMed ID: 33745831
[TBL] [Abstract][Full Text] [Related]
31. The Effect of Gender-Affirming Hormone Therapy on the Risk of Subclinical Atherosclerosis in the Transgender Population: A Systematic Review.
Moreira Allgayer RMC; Borba GDS; Moraes RS; Ramos RB; Spritzer PM
Endocr Pract; 2023 Jun; 29(6):498-507. PubMed ID: 36603652
[TBL] [Abstract][Full Text] [Related]
32. Effect of gender-affirming hormone therapy on hair growth: a systematic review of the literature.
Tang GT; Zwickl S; Sinclair R; Zajac JD; Cheung AS
Clin Exp Dermatol; 2023 Sep; 48(10):1117-1127. PubMed ID: 37311161
[TBL] [Abstract][Full Text] [Related]
33. Gender-Affirming Hormone Therapy and Bone Health: Do Different Regimens Influence Outcomes in Transgender Adults? A Narrative Review and Call for Future Studies.
Cirrincione LR; Narla RR
J Appl Lab Med; 2021 Jan; 6(1):219-235. PubMed ID: 33432334
[TBL] [Abstract][Full Text] [Related]
34. Antiandrogen or estradiol treatment or both during hormone therapy in transitioning transgender women.
Haupt C; Henke M; Kutschmar A; Hauser B; Baldinger S; Saenz SR; Schreiber G
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013138. PubMed ID: 33251587
[TBL] [Abstract][Full Text] [Related]
35. The Amsterdam Cohort of Gender Dysphoria Study (1972-2015): Trends in Prevalence, Treatment, and Regrets.
Wiepjes CM; Nota NM; de Blok CJM; Klaver M; de Vries ALC; Wensing-Kruger SA; de Jongh RT; Bouman MB; Steensma TD; Cohen-Kettenis P; Gooren LJG; Kreukels BPC; den Heijer M
J Sex Med; 2018 Apr; 15(4):582-590. PubMed ID: 29463477
[TBL] [Abstract][Full Text] [Related]
36. Transgender health and the impact of aging and menopause.
Cheung AS; Nolan BJ; Zwickl S
Climacteric; 2023 Jun; 26(3):256-262. PubMed ID: 37011669
[TBL] [Abstract][Full Text] [Related]
37. Position statement on the hormonal management of adult transgender and gender diverse individuals.
Cheung AS; Wynne K; Erasmus J; Murray S; Zajac JD
Med J Aust; 2019 Aug; 211(3):127-133. PubMed ID: 31271465
[TBL] [Abstract][Full Text] [Related]
38. Estrogen-Based Gender-Affirming Hormone Therapy and Subclinical Cardiovascular Disease in Transgender Women with HIV.
Martinez CA; Rikhi R; Fonseca Nogueira N; Pester MS; Salazar AS; Ashinne B; Aguilar N; Melara A; Porras V; Parker M; Mendez A; Cyrus E; De Santis JP; Jones DL; Brown TT; Hurwitz BE; Alcaide ML
LGBT Health; 2023; 10(8):576-585. PubMed ID: 37459150
[No Abstract] [Full Text] [Related]
39. Characteristics and gender affirming healthcare needs of transgender and non-binary students starting hormone therapy in a student health service in Aotearoa New Zealand.
Carroll R; Sepulveda B; McLeod L; Stephenson C; Carroll RW
J Prim Health Care; 2023 Jun; 15(2):106-111. PubMed ID: 37390028
[TBL] [Abstract][Full Text] [Related]
40. Gender-affirming hormone therapy induces specific DNA methylation changes in blood.
Shepherd R; Bretherton I; Pang K; Mansell T; Czajko A; Kim B; Vlahos A; Zajac JD; Saffery R; Cheung A; Novakovic B
Clin Epigenetics; 2022 Feb; 14(1):24. PubMed ID: 35177097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
